Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
May activate transcription. Additionally we are shipping PTOV1 Proteins (6) and many more products for this protein.
Showing 10 out of 43 products:
Human Polyclonal PTOV1 Primary Antibody for EIA, IHC (p) - ABIN954371
Morote, Fernández, Alaña, Iglesias, Planas, Reventós, Ramón Y Cajal, Paciucci, de Torres: PTOV1 expression predicts prostate cancer in men with isolated high-grade prostatic intraepithelial neoplasia in needle biopsy. in Clinical cancer research : an official journal of the American Association for Cancer Research 2008
Show all 5 references for ABIN954371
Human Polyclonal PTOV1 Primary Antibody for ICC, IF - ABIN4348560
Lei, Zhang, Li, Lin, Wu, Li, Liu: Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer. in BMC cancer 2014
Show all 2 references for ABIN4348560
Cow (Bovine) Polyclonal PTOV1 Primary Antibody for WB - ABIN2784251
Santamaría, Castellanos, Gómez, Benedit, Renau-Piqueras, Morote, Reventós, Thomson, Paciucci: PTOV1 enables the nuclear translocation and mitogenic activity of flotillin-1, a major protein of lipid rafts. in Molecular and cellular biology 2005
Show all 2 references for ABIN2784251
PTOV1 is associated with UCH-L1 (show UCHL1 Antibodies) and in response to estrogen stimuli during the mouse oocyte development
High PTOV1 expression was associated with invasive urothelial carcinoma.
PTOV1 overexpression is associated with poor survival outcomes of nasopharyngeal carcinoma patients.
PTOV1 protein abnormal expression might contribute to the malignant progression of epithelial ovarian cancer.
Our study demonstrated that PTOV1 overexpression is correlated with increased aggressiveness of hepatocellular carcinoma and could be a prognostic biomarker for patients with HCC (show FAM126A Antibodies)
The study showed that PTOV1 is upregulated in breast cancer cell lines and clinical samples, and its expression was positively associated with progression and aggressiveness of breast cancer, suggesting that PTOV1 could serve as an independent prognostic marker.
In prostate tumors, the overexpression of PTOV1 was associated with decreased expression of HEY1 and HES1, and this correlation was significant in metastatic lesions.
RA-induced cancer cell cytotoxicity was significantly impaired by Zyxin (show ZYX Antibodies) or PTOV1. Overall, our findings suggest that Zyxin (show ZYX Antibodies) and PTOV1 should be considered as critical determinants in cancer therapy with retinoids
alpha-Methyl-CoA racemase can be considered a more accurate marker than PTOV1 in the identification of high-grade prostatic intraepithelial neoplasia (HGPIN) and of prostate cancer.
PTOV1 expression is associated to more aggressive human carcinomas and more significantly to bladder carcinomas suggesting that this protein is a potential new marker of aggressive disease in the latter tumors.
MED25 (show MED9 Antibodies) and PTOV1 differentially modulate retinoic acid sensitivity in cancer cells depending on their expression levels.
May activate transcription. Required for nuclear translocation of FLOT1. Promotes cell proliferation (By similarity).
granule cell antiserum positive 3
, prostate tumor-overexpressed gene 1 protein homolog
, activator interaction domain-containing protein 2
, prostate tumor overexpressed gene 1
, prostate tumor-overexpressed gene 1 protein
, prostate tumor over expressed gene 1